Kent Thoelke is a pioneering healthcare executive with over 30 years of clinical research experience. As CEO of Paradigm Health, he leads the company’s mission to create equitable access to superior healthcare for patients worldwide. Prior to joining Paradigm Health, Kent served as Chief Innovation Officer at ICON plc following its acquisition of PRA Health Sciences, where he was Chief Scientific Officer. Throughout his career at these organizations, he has driven digital transformation in clinical trials and championed data-driven approaches to make drug development more efficient and equitable across multiple therapeutic areas and geographic regions.
